Abstract
Gestational diabetes mellitus (GDM) is a topic of major interest, as it affects up to 16% of pregnant women and may lead to adverse pregnancy outcomes, which, however, are preventable by appropriate treatment. The aim of the present study was to discuss basic concepts and to critically appraise recent updates on practical issues in the field of GDM. GDM pathophysiology, long-term complications including “fetal programming” and GDM diagnosis are discussed, while clinical practice guidelines on follow-up, medical nutrition therapy, oral hypoglycemic agents and insulin treatment are also reviewed. GDM comprises a serious yet preventable public health problem and prevention by lifestyle changes, early detection and adequate treatment can lead to better health outcomes for both mothers with GDM and their offspring.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Halperin IJ and Feig DS, 2014 The role of lifestyle interventions in the prevention of gestational diabetes. Curr Diab Rep 14: 452.
Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, 2005 Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352: 2477–2486.
Bluestone JA, Herold K, Eisenbarth G, 2010 Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464: 1293–1300.
American Diabetes Association, 2011 Standards of medical care in diabetes- 2011. Diabetes Care 34: Suppl 1: 11–61.
Metzger BE, Buchanan TA, Coustan DR, et al, 2007 Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 30: Suppl 2: 251–260.
Catalano PM, Vargo KM, Bernstein IM, Amini SB, 1991 Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol 165: 914–919.
Kjos SL, Buchanan TA, Greenspoon JS, Montoro M, Bernstein GS, Mestman JH, 1990 Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months post partum. Am J Obstet Gynecol 163: 93–98.
Getahun D, Fassett MJ, Jacobsen SJ, 2010 Gestational diabetes: risk of recurrence in subsequent pregnancies. Am J Obstet Gynecol 203: 467.e1–6.
MacNeill S, Dodds L, Hamilton DC, Armson BA, VandenHof M, 2001 Rates and risk factors for recurrence of gestational diabetes. Diabetes Care 24: 659–662.
Moses RG, 1996 The recurrence rate of gestational diabetes in subsequent pregnancies. Diabetes Care 19: 1348–1350.
Feig DS, Zinman B, Wang X, Hux JE, 2008 Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 179: 229–234
Kaaja RJ, Greer IA, 2005 Manifestations of chronic disease during pregnancy. JAMA 294: 2751–2757.
Kintiraki E, Goulis DG, Mameletzi S, et al, 2013 Large- and small-for-gestational-age neonates born by women with gestational diabetes mellitus diagnosed by the new IADPSG criteria: a case-control study of 289 patients and 1 108 controls. Exp Clin Endocrinol Diabetes 121: 262–265.
Dodd JM, Crowther CA, Antoniou G, Baghurst P, Robinson JS, 2007 Screening for gestational diabetes: the effect of varying blood glucose definitions in the prediction of adverse maternal and infant health outcomes. Aust N Z J Obstet Gynaecol 47: 307–312.
Parlee SD, Macdougald OA, 2014 Maternal nutrition and risk of obesity in offspring: The Trojan horse of developmental plasticity. Biochim Biophys Acta 1842: 495–506.
Nielsen JH, Haase TN, Jaksch C, et al, 2014 Impact of fetal and neonatal environment on beta cell function and development of diabetes. Acta Obstet Gynecol Scand 93: 1109–1122.
Xiao X, Zheng J, 2014 MicroRNAs: crucial modulators of fetal epigenetic programming in nutrition and glucose metabolism. Chin Med J (Engl) 127: 3521–3523.
Metzger BE, Gabbe SG, Persson B, et al, 2010 International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33: 676–682.
Metzger BE, Gabbe SG, Persson B, et al, 2012 The diagnosis of gestational diabetes mellitus: new paradigms or status quo? J Matern Fetal Neonatal Med 25: 2564–2569.
American Diabetes Association, 2011 Diagnosis and classification of diabetes mellitus. Diabetes Care 34: Suppl 1: 62–69.
Metzger BE, Lowe LP, Dyer AR, et al, 2008 Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358: 1991–2002.
Coustan DR, Lowe LP, Metzger BE, Dyer AR, 2010 The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. Am J Obstet Gynecol 202: 654–656.
Claesson R, Ekelund M, Berntorp K, 2013 The potential impact of new diagnostic criteria on the frequency of gestational diabetes mellitus in Sweden. Acta Obstet Gynecol Scand 92: 1223–1226.
Shang M, Lin L, Ma L, Yin L, 2014 Investigation on the suitability of the International Association of Diabetes and Pregnancy Study Group diagnostic criteria for gestational diabetes mellitus in China. J Obstet Gynaecol 34: 141–145.
Blumer I, Hadar E, Hadden DR, et al, 2013 Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 98: 4227–4249.
de Veciana M, Major CA, Morgan MA, et al, 1995 Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 333: 1237–1241.
Griffiths RJ, Vinall PS, Stickland MH, Wales JK, 1987 Haemoglobin A1c levels in normal and diabetic pregnancies. Eur J Obstet Gynecol Reprod Biol 24: 195–200.
Lurie S, Mamet Y, 2000 Red blood cell survival and kinetics during pregnancy. Eur J Obstet Gynecol Reprod Biol 93: 185–192.
Jovanovic L, Savas H, Mehta M, Trujillo A, Pettitt DJ, 2011 Frequent monitoring of A1C during pregnancy as a treatment tool to guide therapy. Diabetes Care 34: 53–54.
Balsells M, Garcia-Patterson A, Gich I, Corcoy R, 2014 Ultrasound-guided compared to conventional treatment in gestational diabetes leads to improved birthweight but more insulin treatment: systematic review and meta-analysis. Acta Obstet Gynecol Scand 93: 144–151.
Landon MB, Spong CY, Thom E, et al, 2009 A multi-center, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361: 1339–1348.
Salihu HM, Alio AP, Wilson RE, Sharma PP, Kirby RS, Alexander GR, 2008 Obesity and extreme obesity: new insights into the black-white disparity in neonatal mortality. Obstet Gynecol 111: 1410–1416.
Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines; Rasmussen KM, Yaktinen AL (eds) (2009) Weight Gain During Pregnancy: Reexamining the Guidelines. Washington (DC): National Academies Press (US); 2009.
Blomberg M, 2011 Maternal and neonatal outcomes among obese women with weight gain below the new Institute of Medicine recommendations. Obstet Gynecol 117: 1065–1070.
Lain KY, Garabedian MJ, Daftary A, Jeyabalan A, 2009 Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin. Am J Obstet Gynecol 200: 501–506.
Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O, 2000 A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 343: 1134–1138.
Gilbert C, Valois M, Koren G, 2006 Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril 86: 658–663.
Rowan JA, Hague WM, Gao W, Battin MR, Moore MP, 2008 Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 358: 2003–2015.
Vanky E, Stridsklev S, Heimstad R, et al, 2010 Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 95: E448–E455.
Lautatzis ME, Goulis DG, Vrontakis M, 2013 Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review. Metabolism 62: 1522–1534.
Mathiesen ER, Kinsley B, Amiel SA, et al, 2007 Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 30: 771–776.
Wyatt JW, Frias JL, Hoyme HE, et al, 2005 Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. Diabet Med 22: 803–807.
Mathiesen ER, Damm P, Jovanovic L, et al, 2011 Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes. Diabetes Metab Res Rev 27: 543–551.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Poulakos, P., Mintziori, G., Tsirou, E. et al. Comments on gestational diabetes mellitus: from pathophysiology to clinical practice. Hormones 14, 335–344 (2015). https://doi.org/10.14310/horm.2002.1570
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1570